↓ Skip to main content

Evidence-based practice in Behçet’s disease: identifying areas of unmet need for 2014

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

blogs
1 blog
twitter
7 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
35 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evidence-based practice in Behçet’s disease: identifying areas of unmet need for 2014
Published in
Orphanet Journal of Rare Diseases, January 2014
DOI 10.1186/1750-1172-9-16
Pubmed ID
Authors

Robert J Barry, Bharat Markandey, Rahul Malhotra, Henry Knott, Nikita Joji, Mohammed Mubin, Alastair K Denniston, Phillip I Murray

Abstract

Behçet's Disease (BD) is characterized by a relapsing-remitting course, with symptoms of varying severity across almost all organ systems. There is a diverse array of therapeutic options with no universally accepted treatment regime, and it is thus important that clinical practice is evidence-based. We reviewed all currently available literature describing management of BD, and investigated whether evidence-based practice is possible for all disease manifestations, and assessed the range of therapeutic options tested.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Unknown 34 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 14%
Student > Ph. D. Student 5 14%
Other 4 11%
Student > Doctoral Student 3 9%
Professor 3 9%
Other 11 31%
Unknown 4 11%
Readers by discipline Count As %
Medicine and Dentistry 17 49%
Agricultural and Biological Sciences 4 11%
Psychology 3 9%
Engineering 2 6%
Nursing and Health Professions 1 3%
Other 1 3%
Unknown 7 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2020.
All research outputs
#2,937,408
of 24,878,531 outputs
Outputs from Orphanet Journal of Rare Diseases
#395
of 2,991 outputs
Outputs of similar age
#33,975
of 319,824 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#6
of 60 outputs
Altmetric has tracked 24,878,531 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,991 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 319,824 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.